View of Prolonged survival with 9 years of continuous use of sorafenib in unresectable hepatocellular carcinoma: a case report

Return to Issue Details Prolonged survival with 9 years of continuous use of sorafenib in unresectable hepatocellular carcinoma: a case report Download Download PDF